Health ministry notifies new rules for drugs and clinical trials

The aim is to make faster accessibility of new drugs to Indian population, Drugs Controller General of India S Eswara Reddy said.

Scroll Staff

· Mar 26, 2019 · 02:42 pm

Bad news for patients as the government weakens the drug price regulator and meddles with price caps

A new committee has been set up to make recommendations to the National Pharmaceutical Pricing Authority and, in effect, take over its function.

S Srinivasan

· Mar 08, 2019 · 02:30 pm

Delhi HC judgment on oxytocin calls out government on its arbitrary order

A close look shows that the judgment relied on several file notings saying that was no data to support the allegation of oxytocin misuse.

Prashant Reddy

· Dec 28, 2018 · 02:30 pm

Delhi High Court lifts Centre’s restrictions on manufacture and sale of oxytocin by private firms

The court called the decision arbitrary and unreasonable and said it was without scientific basis.

Scroll Staff

· Dec 14, 2018 · 04:33 pm

South Africa’s legalisation of cannabis is also a step away from its colonial and apartheid past

The South African Constitutional Court has paved the way for the decriminalisation of marijuana for private use.

Thembisa Waetjen, The Conversation

· Sep 25, 2018 · 11:30 pm

India’s ban on 328 drugs is one small step. Now, a giant leap is needed to reform the drug regulator

Pharmaceutical companies continue to challenge the new ban, some claiming that their drugs were approved before new rules were framed in 1988.

Dhvani Mehta

· Sep 20, 2018 · 02:30 pm

Supreme Court exempts Saridon from government’s ban on fixed dose combination drugs

Last week, the Centre had banned the manufacture, sale and distribution of 328 such drugs with immediate effect.

Scroll Staff

· Sep 17, 2018 · 03:51 pm

Delhi High Court allows pharma major Wockhardt to sell its fixed dose combination drug till Tuesday

The company’s anti-inflammatory drug, Ace Proxyvon, was one of the 328 drugs that the Union Health Ministry had banned.

Scroll Staff

· Sep 14, 2018 · 07:42 pm

Health ministry bans 328 fixed dose combination drugs with immediate effect

Around 6,000 brands of drugs, with a combined market size of between Rs 2,000 crore and Rs 2,500 crore, are likely to be affected.

Scroll Staff

· Sep 13, 2018 · 09:26 am

Delhi High Court stays restrictions on manufacture and sale of oxytocin till October

The Union Health Ministry had in April prohibited the import, manufacture and distribution of the drug for domestic use.

Scroll Staff

· Sep 01, 2018 · 10:52 am

Centre allows sale of Oxytocin by private retail chemists from September 1

However, the government’s notification does not mention any relaxation of the ban on manufacture of the life-saving drug by private firms.

Scroll Staff

· Aug 23, 2018 · 11:34 am

India’s plan to restrict life-saving drug could endanger women during childbirth, say experts

Oxytocin is used to stop postpartum bleeding but is also widely misused in health settings and the dairy industry.

Nayantara Narayanan

· Jul 04, 2018 · 05:30 pm